{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson’s disease (PD). Kinase activity is important for the damaging effects of pathogenic mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease linked to mutations in LRRK2, with a specific focus on the role of kinase activity in pathogenicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used cellular models to assess the effects of mutant dardarin on inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing cellular phenotypes associated with mutant dardarin, including inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of constructs and cell culture, Western blotting, confocal microscopy, and phosphorylation assays, which are standard techniques in the field and were applied appropriately to assess the functional impact of the G2019S variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "judgment": "Yes",
          "reasoning": "The paper shows that the G2019S mutation increases kinase activity and is associated with increased inclusion body formation and cell death, supporting the pathogenicity of this variant.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G2019S variant in LRRK2 shows increased kinase activity, inclusion body formation, and cell death in cellular models, strongly supporting its pathogenicity in the context of Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson’s disease (PD). Kinase activity is important for the damaging effects of pathogenic mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease linked to mutations in LRRK2, with a specific focus on the role of kinase activity in pathogenicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used cellular models to assess the effects of mutant dardarin on inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing cellular phenotypes associated with mutant dardarin, including inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of constructs and cell culture, Western blotting, confocal microscopy, and phosphorylation assays, which are standard techniques in the field and were applied appropriately to assess the functional impact of the I2020T variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "judgment": "Yes",
          "reasoning": "The paper shows that the I2020T mutation is associated with increased kinase activity and is found in inclusion bodies, supporting the pathogenicity of this variant.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The I2020T variant in LRRK2 shows increased kinase activity and association with inclusion bodies, moderately supporting its pathogenicity in the context of Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson’s disease (PD). Kinase activity is important for the damaging effects of pathogenic mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease linked to mutations in LRRK2, with a specific focus on the role of kinase activity in pathogenicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used cellular models to assess the effects of mutant dardarin on inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing cellular phenotypes associated with mutant dardarin, including inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of constructs and cell culture, Western blotting, confocal microscopy, and phosphorylation assays, which are standard techniques in the field and were applied appropriately to assess the functional impact of the R1441C variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "judgment": "Yes",
          "reasoning": "The paper shows that the R1441C mutation forms inclusion bodies and is associated with cell death, supporting the pathogenicity of this variant.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The R1441C variant in LRRK2 forms inclusion bodies and is associated with cell death, supporting its pathogenicity in the context of Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson’s disease (PD). Kinase activity is important for the damaging effects of pathogenic mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease linked to mutations in LRRK2, with a specific focus on the role of kinase activity in pathogenicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used cellular models to assess the effects of mutant dardarin on inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing cellular phenotypes associated with mutant dardarin, including inclusion body formation and cell death, which are relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of constructs and cell culture, Western blotting, confocal microscopy, and phosphorylation assays, which are standard techniques in the field and were applied appropriately to assess the functional impact of the Y1699C variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "judgment": "Yes",
          "reasoning": "The paper shows that the Y1699C mutation forms inclusion bodies and is associated with cell death, supporting the pathogenicity of this variant.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Y1699C variant in LRRK2 forms inclusion bodies and is associated with cell death, supporting its pathogenicity in the context of Parkinson's disease."
    }
  ]
}